<?xml version="1.0" encoding="UTF-8"?>
<p id="par0075">Similarly, other extra-respiratory manifestations such as neurological damage should be evaluated. Among the risk factors smoke could be an important factor in COVID-19, vulnerability to respiratory infection and it may be decisive for the developmental of neural injury. Even studies support that smoking can promote the entry of the virus through the signaling of the nicotinic acetylcholine receptor (nAChR), receptors that are found in the lungs but also in the kidney, circulation and brain, in nerve cells that express ACE2
 <xref rid="bib0130" ref-type="bibr">26</xref>, 
 <xref rid="bib0135" ref-type="bibr">27</xref> so, it would be important to consider brain damage within the manifestations. Furthermore, a small percentage of people infected with SARS-CoV-2 manifest conjunctivitis, which could indicate ocular manifestations with this novel virus.
 <xref rid="bib0100" ref-type="bibr">
  <sup>20</sup>
 </xref>
</p>
